Supriya Lifescience IPO will be open from 16 December 2021 to 20 December 2021. Supriya Lifescience IPO GMP Kostak rate and Subject to Sauda updated as of Today. Supriya Lifescience IPO Grey Market Premium has been Started with High Premium Rates, We need to wait for the rates to change with the Market Sentiment in a few days or to Stabilize the Rates.
Supriya Lifescience Ltd is a company that manufactures pharmaceuticals ingredients (“APIs”). Which is constantly doing its development and research work. The company has 39 pharmaceutical APIs with products such as antihistamine, analgesic, anesthetic, vitamins, anti-asthma, and antiallergic. The company has been the largest exporter of Chlorpheniramine Malate and Ketamine. The company contributes 45–55% and 65–70% respectively to hydrochloride API exports. And it is one of the largest exporters of Salbutamol Sulfate from India.
Supriya Lifescience IPO Issue size of ₹700.00 Crores, in which Fresh Issue of ₹200 Crores and Offer For Sale of ₹500.00 Crores and issue price band has been fixed at ₹265-₹274 Per Share. The Supriya Lifescience IPO to be listed Soon on NSE and BSE.
What is Supriya Lifescience IPO GMP Today?
■ The Supriya Lifescience IPO GMP Today Or Grey Market Premium is ₹130-₹140.
What is Supriya Lifescience IPO Kostak Rates Today?
■ The Supriya Lifescience IPO Kostak rate is ₹0.
What is Supriya Lifescience IPO Subject to Sauda Price Today?
■ The Supriya Lifescience IPO Subject to Sauda rates is ₹0.
Supriya Lifescience IPO Approximately Returns?
■ The Supriya Lifescience IPO’s approximate return is 35%-40%. And it can also change according to the Market Sentiment.
Supriya Lifescience IPO GMP Live, Kostak,& Subject to Sauda :
| Date | GMP | Kostak | Subject |
| 28 Dec 2021 | List – ₹425.00 | ₹0 | ₹0 |
| 27 Dec 2021 | ₹130-₹140 | ₹0 | ₹0 |
| 26 Dec 2021 | ₹110-₹120 | ₹0 | ₹0 |
| 25 Dec 2021 | ₹110-₹120 | ₹0 | ₹0 |
| 24 Dec 2021 | ₹110-₹120 | ₹0 | ₹0 |
| 23 Dec 2021 | ₹130-₹140 | ₹0 | ₹0 |
| 22 Dec 2021 | ₹90-₹100 | ₹200 | ₹5000 |
| 21 Dec 2021 | ₹90-₹100 | ₹200 | ₹5000 |
| 20 Dec 2021 | ₹90-₹100 | ₹200 | ₹5000 |
| 19 Dec 2021 | ₹160-₹170 | ₹200 | ₹5000 |
| 18 Dec 2021 | ₹160-₹170 | ₹200 | ₹5000 |
| 17 Dec 2021 | ₹290-₹300 | ₹0 | ₹0 |
| 16 Dec 2021 | ₹290-₹300 | ₹0 | ₹0 |
| 15 Dec 2021 | ₹250-₹260 | ₹0 | ₹0 |
| 14 Dec 2021 | ₹250-₹260 | ₹0 | ₹0 |
| 13 Dec 2021 | ₹260-₹270 | ₹0 | ₹0 |
| 12 Dec 2021 | ₹0-₹0 | ₹0 | ₹0 |
| 11 Dec 2021 | ₹0-₹0 | ₹0 | ₹0 |
Supriya Lifescience IPO Date & Price Band & Details :
| IPO Open : | 16 December 202 |
| IPO Close : | 20 December 2021 |
| IPO Size : | ₹700. Cr |
| Face Value : | ₹2 Rs. Equity Share |
| Price Band : | ₹265–₹274 Per Share |
| Listing On : | BSE, NSE |
| Issue Size : | ₹700. Cr |
| Fresh Issue : | ₹200. Cr |
| Offer For Sale : | ₹500. Cr |
Supriya Lifescience IPO Market Lot :
Supriya Lifescience IPO Minimum Market lot is 1 Lot with 54 shares with ₹14,796 Application amount. The retail investors can apply up to 13 lots with 702 Shares or ₹192,348 amounts.
| Minimum Lot Size : | 1 Lot |
| Minimum Share : | 54 Shares |
| Minimum Amount : | ₹14,796 |
| Maximum Lot Size : | 13 Lot |
| Maximum shares : | 702 Shares |
| Maximum Amount : | ₹192,348 |
Supriya Lifescience IPO Shares Offer :
A Total of 25,547,445 shares are to be bid for the public issue by Supriya Lifescience IPO with 72,99,270 for Fresh issue and 18,248,175 for offer for sale Shares.
| Category | Shares Offers | Amount |
| Fresh issue : | 72,99,270 | ₹200.00 Cr |
| Offer For Sale : | 18,248,175 | ₹500.00 Cr |
| Total : | 25,547,445 | ₹700.00 Cr |
Supriya Lifescience IPO Reservation :
Supriya Lifescience IPO Total Reservation of 25,547,445 shares are to be bid for the public issue by Supriya Lifescience IPO with 19,160,584 for QIB and 38,32,117 for NII 25,54,744 For RII & – Shares EMP.
| Category | Reservation | Shares | Amount |
| QIB : | 75% | 19,160,584 | ₹525.00 Cr |
| NII : | 15% | 38,32,117 | ₹105.00 Cr |
| RII : | 10% | 25,54,744 | ₹70.00 Cr |
| EMP : | – % | – | ₹ |
| Total : | 100% | 25,547,445 | ₹700.00 Cr |
Supriya Lifescience IPO EPS :
The Supriya Lifescience company’s EPS growth is decreasing every year, which is shown to you in the table here.
| Year | EPS Growth in (Rs.) |
| 2020-9M | ₹10.41 |
| 2020 | ₹10.03 |
| 2019 | ₹5.39 |
| 2018 | ₹1.19 |
Supriya Lifescience IPO Peer Comparison PE :
The Supriya Lifescience, According to DRHP of the company some company is listed whose PE Multiple is shown in this table.
| Sr. No. | Company | PE Ratio |
| 1. | Solara Active Pharma Sciences Limited | 44.29 |
| 2. | Neuland Laboratories Limited | 12.63 |
| 3. | Aarti Drugs Limited | 60.57 |
| 4. | Wanbury Limited | 26.90 |
| 5. | Divis Laboratories Limited | 51.85 |
Supriya Lifescience IPO Dates :
Supriya Lifescience IPO Date is 16 December and the close date is 20 December 2021. The allotment will be finalized on 23 December 2021 and the IPO may list on 28 December 2021.
| Open Date : | 16 December 2021 |
| Close Date : | 20 December 2021 |
| Allotment Date : | 23 December 2021 |
| Refund Date : | 24 December 2021 |
| Share Credit Date : | 27 December 2021 |
| Listing Date : | 28 December 2021 |
Supriya Lifescience Company Financial Report (Cr) :
| Year | Revenue | Expense | P&L |
| 2021 | ₹25,993.50 | ₹23,694.00 | ₹1,520.73 |
| 2020 | ₹21,762.53 | ₹21,377.81 | ₹230.24 |
| 2019 | ₹21,591.22 | ₹21,037.06 | ₹851.33 |
About Supriya Lifescience Company
Our Company was incorporated as ‘Supriya Lifescience Limited’ pursuant to a certificate of incorporation dated March 26, 2008, issued by the Registrar of Companies, Maharashtra at Mumbai (“RoC”), upon the conversion of ‘M/s Supriya Chemicals’, a partnership firm, into a public limited company, in accordance with the provisions of Part IX of the Companies Act, 1956. Our Company commenced operations pursuant to a certificate for commencement of business dated April 1, 2008, issued by RoC.
We are one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of March 31, 2021, we have niche product offerings of 39 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic and antiallergic. We have consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-55% and 65-70%, respectively, of the API exports from India, between Fiscal 2017 and 2020. We were among the largest exporters of Salbutamol Sulphate from India in Fiscal 2020 in terms of volume.
Supriya Lifescience IPO GMP FAQs :
How much is Supriya Lifescience IPO GMP Today?
Supriya Lifescience IPO GMP Today is ₹130-₹140.
How much is Supriya Lifescience IPO Grey Market Premium?
Supriya Lifescience IPO is Grey Market Premium ₹130-₹140 .
What is Supriya Lifescience IPO Kostak Rate?
Supriya Lifescience IPO Kostak Rate is ₹0.
What is Supriya Lifescience IPO Subject to Sauda?
Supriya Lifescience IPO Subject to Deals is ₹0.
What are Supriya Lifescience IPO Approx Returns?
Supriya Lifescience IPO approx Returns is 50%-60%. And it can also change according to the Market Sentiment.
| Supriya Lifescience IPO Details: Click Here Supriya Lifescience IPO Subscription: Click Here Supriya Lifescience IPO Allotment: Click Here Supriya Lifescience IPO Listing: Click Here |
All Supriya Lifescience IPO-related links are available here. If you want to know the details then click on Click Here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.